Participating in a marathon is a pretty amazing feat for anyone, but five people taking part in the 26.2-mile Bank of America Chicago Marathon on Oct. 7 share something that makes this amazing feat extra special: all of them were formerly dependent on insulin, but have had an islet cell transplant and are now living their lives diabetes-free!
Islet cell transplantation is what connects the five together as members of the athletic team Cellmates On The…
Read more »
By
AmyT on
January 17, 2012
In the area of beta cell preservation, there’s a (sort of) new name in the spotlight: Andromeda Biotech, Ltd. with its DiaPep277 treatment. Based in Israel, this company announced last month that phase III clinical trials showed significant preservation of C-peptide levels, a marker for assessing insulin secretion by pancreatic cells. Andromeda joins the ranks of companies like Tolerx and Macrogenics/Lilly, who’ve been vocal about their work to preserve beta cell functioning in newly diagnosed patients…
Read more »
Another “myth-busters” post:
There are a lot of things about diabetes that are taken as “gospel,” both by doctors and patients. But at the JDRF Capitol Research Summit last month, I learned that many commonly accepted beliefs about diabetes haven’t actually been proven by medical science with convincing evidence (far beyond ‘you got it because you ate too much candy.’) Eminent scholar Dr. Mark Atkinson was pretty adamant that “these ideas need to be put…
Read more »
